Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.08
-$0.04-3.57%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 63.72% | 216.17% | 214.35% | 161.25% | 317.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 63.72% | 216.17% | 214.35% | 161.25% | 317.48% |
| Cost of Revenue | 139.26% | 486.79% | 1,083.67% | 708.33% | 1,025.00% |
| Gross Profit | -63.75% | -6.20% | -40.72% | 2.42% | 102.53% |
| SG&A Expenses | -14.94% | -12.56% | -8.55% | 1.58% | -15.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.48% | -7.56% | -3.44% | -11.96% | -15.80% |
| Operating Income | 4.30% | 14.40% | 9.75% | 15.37% | 19.62% |
| Income Before Tax | 11.16% | 20.55% | 16.10% | 8.95% | 13.56% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.16% | 20.55% | 16.10% | 8.95% | 13.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.16% | 20.55% | 16.10% | 8.95% | 13.56% |
| EBIT | 4.30% | 14.40% | 9.75% | 15.37% | 19.62% |
| EBITDA | 4.19% | 14.27% | 9.55% | 15.19% | 19.46% |
| EPS Basic | 21.23% | 30.02% | 24.84% | 16.25% | 22.22% |
| Normalized Basic EPS | 15.61% | 25.48% | 19.93% | 22.33% | 26.69% |
| EPS Diluted | 21.23% | 30.02% | 24.84% | 16.25% | 22.22% |
| Normalized Diluted EPS | 15.61% | 25.48% | 19.93% | 22.33% | 26.69% |
| Average Basic Shares Outstanding | 11.67% | 13.38% | 12.08% | 10.04% | 9.94% |
| Average Diluted Shares Outstanding | 11.67% | 13.38% | 12.08% | 10.04% | 9.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |